ubenimex has been researched along with sirolimus in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dzierzbicka, K; Kołodziejczyk, AM; Myśliwski, A; Romanowski, P | 1 |
| Liu, S; Liu, X; Liu, Z; Niu, Z; Sun, L; Wang, H; Xie, F | 1 |
1 review(s) available for ubenimex and sirolimus
| Article | Year |
|---|---|
[Synthetic immunomodulators designed on the basis of natural products of microorganisms].
Topics: Adjuvants, Immunologic; Cord Factors; Cyclosporine; Glucans; Humans; Immunity; Immunosuppressive Agents; Lentinan; Leucine; Lipid A; Peptides; Polyenes; Sirolimus; Tacrolimus | 1991 |
1 other study(ies) available for ubenimex and sirolimus
| Article | Year |
|---|---|
Ubenimex inhibits cell proliferation, migration and invasion in renal cell carcinoma: the effect is autophagy-associated.
Topics: Adenine; Adult; Aged; Aged, 80 and over; Aminopeptidases; Antibiotics, Antineoplastic; Autophagy; Carcinoma, Renal Cell; Caspase 3; Cell Line, Tumor; Cell Movement; Cell Proliferation; Gene Expression Regulation, Neoplastic; Humans; Kidney Neoplasms; Leucine; Middle Aged; Neoplasm Invasiveness; Sirolimus; Wound Healing; Young Adult | 2015 |